Latest Advancements in CAR-T Therapy with Dr. Ehsan Malek
This event will not be live streamed. You can submit your questions in advance by clicking the button "Notify when available"
Listen to this podcast to learn from Dr. Ehsan Malek, a hematologist oncologist at Roswell Park, about some of the major breakthroughs in CAR T therapy in 2024 and what is on the horizon in 2025.
Hannah Loosle
Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding. Hannah enjoys baking and going to concerts in her free time.
Ehsan Malek, MD
Dr. Ehsan Malek is a hematology oncology specialist at Roswell Park Comprehensive Cancer Center, specializing in an array of plasma cell disorders. He earned his medical degree in Iran and completed a fellowship in hematology and oncology at the University of Cincinnati. Dr. Malek is the Director of the Multiple Myeloma Translational Research Program at Roswell Park, and is involved in developing novel cellular and immune-based therapeutic strategies that promise improved outcomes and enhanced quality of life for patients.